Presentation TCT 2022 Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial Presenter: Christos Rammos September 17, 2022
Presentation TCT 2022 TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy Presenter: Mick Renkens September 17, 2022
Presentation TCT 2022 TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial Presenter: Dennis Narcisse September 17, 2022
Presentation TCT 2022 TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial Presenter: Donggyu Moon September 17, 2022
Presentation TCT 2022 TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg ) Presenter: Yoshinobu Onuma September 17, 2022
Presentation TCT 2022 TCT 54: Bifurcation Left Main Coronary Stenting with or without intracoronary imaging: Outcomes From the European Bifurcation Club Left Main trial Presenter: Annette Maznyczka September 17, 2022
Presentation TCT 2022 TCT 22: Clopidogrel versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients with Acute Coronary syndrome: Subgroup Analysis of the HOST-EXAM trial Presenter: Jeehoon Kang September 17, 2022
Presentation TCT 2022 TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes Presenter: Matthias Lutz September 17, 2022
Presentation TCT 2022 TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials Presenter: Toshiki Kuno September 17, 2022
Presentation TCT 2022 TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial Presenter: Alexander Fanaroff September 17, 2022
Presentation TCT 2022 TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial Presenter: Zardasht Oqab September 17, 2022
Presentation TCT 2022 TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial Presenter: Kevin Bainey September 17, 2022
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Industry News TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism September 13, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News ESC 2022 Routine Functional Testing Unnecessary After Stenting: POST-PCI Yael L. Maxwell September 06, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2022 Shelley Wood September 01, 2022